Takeshi Ichikawa

1.8k total citations
75 papers, 1.4k citations indexed

About

Takeshi Ichikawa is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Takeshi Ichikawa has authored 75 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 22 papers in Hepatology and 15 papers in Surgery. Recurrent topics in Takeshi Ichikawa's work include Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (8 papers) and Plant Pathogenic Bacteria Studies (8 papers). Takeshi Ichikawa is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (8 papers) and Plant Pathogenic Bacteria Studies (8 papers). Takeshi Ichikawa collaborates with scholars based in Japan, United States and China. Takeshi Ichikawa's co-authors include Setsuo SERIZAWA, Shinji Tsuyumu, Y. Takikawa, Masao GOTO, Masahiko Negishi, Raija L.P. Lindberg, Barbara A. Burkhart, Masatomo Mori, Hitoshi Takagi and I. Ishida and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Takeshi Ichikawa

70 papers receiving 1.4k citations

Peers

Countries citing papers authored by Takeshi Ichikawa

Since Specialization

Citations

This map shows the geographic impact of Takeshi Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Ichikawa more than expected).

Fields of papers citing papers by Takeshi Ichikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Ichikawa. The network helps show where Takeshi Ichikawa may publish in the future.

Co-authorship network of co-authors of Takeshi Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Ichikawa. A scholar is included among the top collaborators of Takeshi Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Ichikawa. Takeshi Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inflammatory sarcopenia, a novel concept in chronic liver disease: insights from magnetic resonance imaging biomarkers 2025 ·Translational Gastroenterology and Hepatology ·Atsushi Nakamura, (unknown), (unknown), Takeshi Ichikawa, Keiji Okuyama	0
2	Liver Disease-Related Sarcopenia: A Predictor of Poor Prognosis by Accelerating Hepatic Decompensation in Advanced Chronic Liver Disease 2023 ·Cureus ·Atsushi Nakamura, (unknown), Takeshi Ichikawa	2
3	Mildly Low Serum Sodium Levels in Chronic Liver Disease: At Risk for Sarcopenia and Portal Hypertension 2023 ·Cureus ·Atsushi Nakamura, (unknown), Takeshi Ichikawa	3
4	Pathogenic and Compensatory Mechanisms in Epidermis of Sphingomyelin Synthase 2-Deficient Mice 2021 ·Skin Pharmacology and Physiology ·Shota Sakai, Asami Makino, (unknown), Takeshi Ichikawa, Tadashi Yamashita, Makoto Taniguchi, Yoshihiro Tokudome, Yoshio Hirabayashi, Masashi Akiyama, Debra Crumrine, Yoshikazu Uchida, Peter M. Elias, Tetsuya Tsuchida, Sumiko Hamanaka	4
5	Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization 2016 ·Oncology ·Takeshi Ichikawa, (unknown), Hiroshi Sasaki, (unknown), Hiroaki Kaneko, (unknown), Itaru Oi, Masayuki Fujino	18
6	Histone Deacetylase Inhibitors Induce Cytochrome P450 2B by Activating Nuclear Receptor Constitutive Androstane Receptor 2010 ·Drug Metabolism and Disposition ·Daichi Takizawa, Satoru Kakizaki, Norio Horiguchi, Hiroki Tojima, Yuichi Yamazaki, Takeshi Ichikawa, Ken Sato, Masatomo Mori	16
7	Antioxidative Activities of Oxindole-3-acetic Acid Derivatives from Supersweet Corn Powder 2010 ·Bioscience Biotechnology and Biochemistry ·Naoki Midoh, Akihito Tanaka, (unknown), Chie Furuta, Katsuya Suzuki, Takeshi Ichikawa, (unknown), (unknown)	11
8	Abdominal Tuberculosis in the Absence of Pulmonary Involvement Shown by 2-[Fluorine 18] Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography 2009 ·Clinical Gastroenterology and Hepatology ·Takeshi Ichikawa, Hitoshi Takagi, Masatomo Mori	7
9	Hepatocyte growth factor protects against Fas‐mediated liver apoptosis in transgenic mice 2009 ·Liver International ·Hideyuki Suzuki, Mitsuo Toyoda, Norio Horiguchi, Satoru Kakizaki, Tatsuya Ohyama, Daichi Takizawa, Takeshi Ichikawa, Ken Sato, Hitoshi Takagi, Masatomo Mori	15
10	Development and commercialization of Trichoderma asperellum SKT-1 (Ecohope^[○!R]), a microbial pesticide(Society Awards 2007(on prominent achievement)) 2007 ·(unknown), Satoshi Watanabe, (unknown), Takeshi Ichikawa, Takahiro Makino	4
11	Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride‐induced chronic liver injury 2007 ·Liver International ·Satoshi Hagiwara, Toshiyuki Otsuka, Yuichi Yamazaki, (unknown), Naondo Sohara, Takeshi Ichikawa, Ken Sato, Satoru Kakizaki, Hitoshi Takagi, Masatomo Mori	8
12	Histological Change After Interferon Therapy in Chronic Hepatitis C in View of Iron Deposition in the Liver 2000 ·Biological Trace Element Research ·Satoru Kakizaki, (unknown), Takeshi Ichikawa, Takehiko Abe, Toshihiko Yamada, Keiji Suzuki, Akira Kojima, Hisashi Takayama, (unknown), (unknown), (unknown)	3
13	Esophageal metastasis of hepatocellular carcinoma 2000 ·Gastrointestinal Endoscopy ·(unknown), Hitoshi Takagi, (unknown), Takeshi Ichikawa, Takehiko Abe, (unknown), (unknown)	9
14	Abnormalities of the FHIT gene in human oral carcinogenesis 2000 ·British Journal of Cancer ·Keiji Tanimoto, Shinichi Hayashi, Eiju Tsuchiya, Yoshio Tokuchi, Yukio Kobayashi, Koji YOSHIGA, Tatsuo Okui, Masao Kobayashi, Takeshi Ichikawa	36
15	Increased Synthesis of Hyaluronate Enhances Motility of Human Melanoma Cells 1999 ·Journal of Investigative Dermatology ·Takeshi Ichikawa, Naoki Itano, Takahiro Sawai, Koji Kimata, (unknown), Toshiaki Saida, Shun’ichiro Taniguchi	59
16	Evaluation of twice‐daily administration of interferon‐β for chronic hepatitis C 1999 ·Journal of Viral Hepatitis ·Satoru Kakizaki, Hitoshi Takagi, Tetsuya Yamada, Takeshi Ichikawa, Takehiko Abe, Naondo Sohara, (unknown), Miki Kaneko, (unknown), Hisashi Takayama, Takahiko Nagamine, Masatomo Mori	15
17	Expression of moesin and its associated molecule CD44 in epithelial skin tumors 1998 ·Journal of Cutaneous Pathology ·Takeshi Ichikawa, Junya Masumoto, (unknown), Toshiaki Saida, Junji Sagara, Shun’ichiro Taniguchi	13
18	Transcatheter arterial embolization-induced bilious pleuritis in a patient with hepatocellular carcinoma 1997 ·Journal of Gastroenterology ·Takeshi Ichikawa, Toshihiko Yamada, (unknown), (unknown), Hideaki Ito, (unknown), (unknown), Masatomo Mori	6
19	Recombinant mouse prolactin: expression in Escherichia coli, purification and biological activity 1992 ·Journal of Molecular Endocrinology ·Mami Yamamoto, (unknown), Takeshi Ichikawa, Kyoko Hoshino, K Nakashima	14
20	Characterization and regulation of sex-specific mouse steroid hydroxylase genes 1990 ·Canadian Journal of Physiology and Pharmacology ·Hidefumi Yoshioka, Raija L.P. Lindberg, Garry Wong, Takeshi Ichikawa, Takao Itakura, Barbara A. Burkhart, Masahiko Negishi	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact